Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Antipsychosis Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1208, Ropper, A.H.,et al, 2014

Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011

Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005

Clomipramine Induced Neuroleptic Malignant Syndrome and Pyrexia of Unknown Origin
BMJ 329:1333-1335, Haddow,A.M.,et al, 2004

Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia: Histology, In Vitro Contracture Tests, and Genetic Characterization
Arch Neurol 61:106-113, Guis,S.,et al, 2004

Neuroleptic Malignant-Like Syndrome Due to Donepezil and Maprotiline
Neurol 60:1050-1051, Ohkoshi,N.,et al, 2003

Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes
Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease
Neurol 52:777-781, Ueda,M.,et al, 1999

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998

Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998

Calcium Channels in Neurological Disease
Ann Neurol 42:275-282, Greenberg,D.A., 1997

Neuroleptic Malignant Syndrome
JNNP 58:271-273, Buckley,P.F.&Hutchinson,M., 1995

Epileptic Seizures in Patients with Acute Catatonic Syndrome
JNNP 57:1419-1422, Primavera,A.,et al, 1994

Malignant Brain Stem Hyperthermia Caused by Brain Stem Hemorrhage
Stroke 25:518-520, Kitanaka,C.,et al, 1994

Hyperthermia and Heatstroke
Hospital Practice 29:65-68, 73, 78-80994., Simon,H.B., 1994

The Nondystrophic Myotonias
In Myology, McGraw-Hill, 2nd Ed, Ch49, p1291-13024., Rudel,R.,et al, 1994

How"Malignant"is the Neuroleptic Malignant Syndrome
BMJ 307:1223-1224, Bristow,M.F.&Kohen,D., 1993

Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992

Detecting Susceptibility to Malignant Hyperthermia
BMJ 304:791-792, Ellis,F.R., 1992

Neuroleptic-Induced Catatonia as a Stage in the Progression Toward NMS
J Am Acad Child Adolesc Psychiatry 31:1161-1164, Woodbury,M.M.&Woodbury,M.A., 1992

Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991

Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991

Serum Iron and Neuroleptic Malignant Syndrome
Lancet 338:149-151, Rosebush,P.I.&Mazurek,M.F., 1991

Neuroleptic Malignant Syndrome:A Unique Association with a Tricyclic Antidepressant
Neurol 40:1797-1798, Baca,L.&Martinelli,L., 1990

Cerebellar Degeneration in Neuroleptic Malignant Synd:Neuropath & Review of Lit Concerning Heat-Related Nervous Syst Injury
JNNP 52:387-391, Lee,S.,et al, 1989

Improved Diagnosis of Becker Muscular Dystrophy by Dystrophin Testing
Neurol 39:1011-1017, Hoffman,E.P.,et al, 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Neuroleptic Malignant Syndrome:A Case Report with Post-Mortem Brain and Muscle Pathology
JNNP 52:1006-1009, Jones,E.M.&Dawson,A., 1989

Protracted Neuroleptic Malignant Syndrome Complicating Long-Acting Neuroleptic Administration
Am J Med 85:875-878, Legras,A.,et al, 1988

Neuroleptic Malignant Syndrome in an Elderly Patient
BMJ 296:18, Finucane,P., 1988

Neuroleptic Malignant Syndrome:Review and Analysis of 115 Cases
Biol Psychiatry 22:1004-1020, Addonizio,G.,et al, 1987

Peripheral Neuropathy as a Component of the Neuroleptic Malignant Syndrome
Am J Med 82:169-170, Anderson,S.A.&Weinschenk,K., 1987

Central Core Disease, Clinical Features in 13 Patients
Medicine 66:389-396, Shuaid,A.,et al, 1987

Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987

The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986

Successful Treatment of Neuroleptic Malignant Syndrome with Sodium Nitroprusside
Ann Int Med 104:56-57, Blue,M.G.,et al, 1986

Neuroleptic Malignant Syndrome, Successful Treatment with Pancuronium
JAMA 254:2795-2796, Sangal,R.&Dimitrijevic,R., 1985

A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985

Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985

Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984

Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984

Neuroleptic Malignant Syndrome Complicated by Disseminated Intravascular Coagulation
Arch Int Med 144:1296-1297, Eles,G.R.,et al, 1984

The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983

Neuroleptic Malignant Syndrome:Response to Dantrolene Sodium
Ann Int Med 98:183-184, May,D.C.,et al, 1983

Beneficial Effects of Dantrolene in the Treatment of Neuroleptic Malignant Syndrome:A Report of Two Cases
Neurol 33:516-518, Goulon,M.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983